GSGurmeet Singh

Gurmeet Singh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gurmeet Singh has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical and echocardiographic outcomes of combined CABG and MV repair

    by Rajat Sindwani, Gurmeet Singh, Harneet Singh Khurana, Samir Kapoor, Vikrampal Singh, Sarju Ralhan, Rajesh Chand Arya, Rajiv Kumar Gupta

    A mixed-method observational study evaluated patients undergoing Coronary Artery Bypass Grafting (CABG) with mitral valve (MV) repair for moderate to severe mitral regurgitation (MR). Most patients aged between 61–70 years (46.3%) and with 60% being male, 73% with Type 2 diabetes and 83.33% with triple-vessel coronary artery disease (CAD) (83.8%) and 15% with left main CAD. At discharge, 94.7% improved to NYHA class II and residual MR was eliminated in 97.1% patients. This study demonstrates significantly improved 12-month outcomes, with elimination of residual MR, supporting CABG with concomitant MV repair as a viable option for IMR patients despite high comorbidity.

  • Open Access

    An empirical study on the impact of genetics and gender and its consequences in hypertrophic cardiomyopathy

    by Anshuman Gupta, Harneet Singh Khurana, Gurmeet Singh

    Background: Gender-associated variations in phenotypic expression and their consequences are established in numerous cardiac circumstances. However, their impact is questionable in the case of HCM. Objective: To investigate the demographic and clinical profiles of the HCM patients. Also, to compare the echocardiographic features according to the HCM subtypes in the study populace. Methodology: The present study was conducted at the DMCH, Ludhiana, from March 2019 to May 2021, using a prospective observational and non-blinded design. The data regarding demographic and clinical profile are gathered for the specified duration. The clinical features are confirmed through the Echocardiography. The gathered data are analyzed through chi-square to determine the differences among the groups with the aid of the SPSS tool. Results and discussion: The demographic profiles and clinical assessment of 103 patients are analyzed. The subjective assessment reveals that HCM is predominantly in males in a ratio of 2.1:1. Dyspnea is a chief complaint of both genders (77.67%). Apical type is prevalent in male HCM patients. MYBPC3 and MYH7 are the general mutations found in the genetic tests. SCD is found in patients possessing this type of genetic mutation. The non-obstructive type is more common than the obstructive type. Conclusions: HCM is a chronic disease and causes morbidity as well as mortality globally. HCM patients are vulnerable to SCD and stroke. These risk factors rely on the diagnosis associated with age, gender, obstruction, obesity, and coronary diseases. Hence, the present research on the demographic characteristics of HCM patients promotes awareness regarding the complications among the Indian populace.

  • Open Access

    Analysis of Anticoagulation Therapy Related Complications in Patients With Prosthetic Valves

    by Vikrampal Singh, Arun Garg, Gurmeet Singh, Samir Kapoor, Sarju Ralhan, Rajesh Arya, Bishav Mohan, Gurpreet S Wander, Rajiv K Gupta

    Purpose: The aim of this study is to analyze anticoagulation-related complications in patients following mechanical valve replacement and factors influencing the outcome. Materials and Methods: A total of 250 patients were analyzed during OPD follow-up for anticoagulation-related complications and various factors influencing outcome. Patients received prosthetic valve at mitral and/or aortic or both. Results: Out of 250 patients, 48% were male and 52% were female. The mean age was 41.9 ± 14.4. A total of 139 had mitral valve replacement (MVR), 70 had aortic valve replacement (AVR), 40 had double valve replacement (DVR), and 1 patient had triple valve replacement. Valves implanted were mechanical bileaflet valve. The mean international normalization ratio (INR) in the study was 2.4 ± 0.56. A total of 49 events occurred during follow-up, of which 4.5% per patient years were anticoagulation-related hemorrhagic events and 4.8% per patient years were thromboembolic events. Among thromboembolic events, valve thrombosis occurred in 10 patients and cerebrovascular accidents occurred in 11 patients. Mean INR for thromboembolic events was 1.46 ± 0.25 and anticoagulation-related hemorrhagic events was 4.4 ± 1.03. Mortality rate was 1.6% in AVR, 4% in MVR, and 0.4% in DVR groups; about 34% of patients needed dose modification of Acenocoumarol and reason for derangement of INR was associated with infectious process and poor compliance; 85% of cases showed good compliance for daily anticoagulation therapy. Conclusion: Anticoagulation for mechanical valve replacement can be managed with INR range of 2.0 to 2.5 in MVR and 1.5 to 2.0 in AVR with acceptable hemorrhagic and thromboembolic events. We must educate and counsel the patients during follow-up for better compliance to optimal anticoagulation.